A Retrospective, observational study on the safety of in-utero exposure to Tenofovir Disoproxil Fumarate in HIV exposed uninfected infants

Trial Profile

A Retrospective, observational study on the safety of in-utero exposure to Tenofovir Disoproxil Fumarate in HIV exposed uninfected infants

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Sep 2016

At a glance

  • Drugs Tenofovir disoproxil fumarate (Primary) ; Antiretrovirals
  • Indications HIV infections
  • Focus Adverse reactions
  • Most Recent Events

    • 30 Sep 2016 New trial record
    • 24 Aug 2016 Results published in the AIDS
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top